0 0 1 0 1 B-lower_bound
- 1 2 1 2 O
21 2 4 2 4 B-upper_bound
years 5 10 5 10 I-upper_bound
of 11 13 11 13 O
age 14 17 14 17 B-age

Adequate 0 8 18 26 O
liver 9 14 27 32 O
function 15 23 33 41 O
defined 24 31 42 49 O
as 32 34 50 52 O
total 35 40 53 58 B-clinical_variable
bilirubin 41 50 59 68 I-clinical_variable
≤ 51 52 69 70 O
1.5 53 56 71 74 B-upper_bound
x 57 58 75 76 I-upper_bound
upper 59 64 77 82 I-upper_bound
limit 65 70 83 88 I-upper_bound
of 71 73 89 91 I-upper_bound
normal 74 80 92 98 I-upper_bound
( 81 82 99 100 I-upper_bound
ULN 82 85 100 103 I-upper_bound
) 85 86 103 104 I-upper_bound
for 87 90 105 108 O
age 91 94 109 112 B-age

Age 0 3 113 116 B-age
< 4 5 117 118 O
22 6 8 119 121 B-upper_bound
years 9 14 122 127 I-upper_bound
( 15 16 128 129 O
eligible 16 24 129 137 O
until 25 30 138 143 O
22nd 31 35 144 148 O
birthday 36 44 149 157 O
) 44 45 157 158 O

Creatinine 0 10 159 169 B-clinical_variable
clearance 11 20 170 179 I-clinical_variable
or 21 23 180 182 O
radioisotope 24 36 183 195 B-clinical_variable
GFR 37 40 196 199 I-clinical_variable
≥ 41 42 200 201 O
70 43 45 202 204 B-lower_bound
mL 46 48 205 207 I-lower_bound
/ 48 49 207 208 I-lower_bound
min/1.732 49 58 208 217 I-lower_bound

Female 0 6 218 224 B-gender
participants 7 19 225 237 I-gender
who 20 23 238 241 O
are 24 27 242 245 O
breast 28 34 246 252 O
feeding 35 42 253 260 O
must 43 47 261 265 O
agree 48 53 266 271 O
to 54 56 272 274 O
stop 57 61 275 279 O
breast 62 68 280 286 O
feeding 69 76 287 294 O

Female 0 6 295 301 B-gender
participants 7 19 302 314 I-gender
≥ 20 21 315 316 O
10 22 24 317 319 B-lower_bound
years 25 30 320 325 I-lower_bound
of 31 33 326 328 O
age 34 37 329 332 B-age
or 38 40 333 335 O
post 41 45 336 340 O
- 45 46 340 341 O
menarchal 46 55 341 350 O
must 56 60 351 355 O
have 61 65 356 360 O
a 66 67 361 362 O
negative 68 76 363 371 B-pregnancy
serum 77 82 372 377 I-pregnancy
or 83 85 378 380 O
urine 86 91 381 386 B-pregnancy
pregnancy 92 101 387 396 I-pregnancy
test 102 106 397 401 O
within 107 113 402 408 O
24 114 116 409 411 B-upper_bound
hours 117 122 412 417 I-upper_bound
prior 123 128 418 423 I-upper_bound
to 129 131 424 426 O
beginning 132 141 427 436 O
treatment 142 151 437 446 B-treatment

Females 0 7 447 454 B-gender
of 8 10 455 457 O
child 11 16 458 463 O
- 16 17 463 464 O
bearing 17 24 464 471 O
potential 25 34 472 481 O
can 35 38 482 485 O
not 38 41 485 488 O
be 42 44 489 491 O
pregnant 45 53 492 500 B-pregnancy
or 54 56 501 503 O
breast 57 63 504 510 O
- 63 64 510 511 O
feeding 64 71 511 518 O

High 0 4 519 523 O
- 4 5 523 524 O
risk 5 9 524 528 O
: 9 10 528 529 O
Embryonal 11 20 530 539 B-cancer
, 20 21 539 540 O
botryoid 22 30 541 549 B-cancer
, 30 31 549 550 O
spindle 32 39 551 558 B-cancer
cell 40 44 559 563 I-cancer
, 44 45 563 564 O
alveolar 46 54 565 573 B-cancer
, 54 55 573 574 O
undifferentiated 56 72 575 591 B-cancer
, 72 73 591 592 O
or 74 76 593 595 O
anaplastic 77 87 596 606 B-cancer
RMS 88 91 607 610 I-cancer
with 92 96 611 615 O
metastatic 97 107 616 626 B-cancer
disease 108 115 627 634 I-cancer
at 116 118 635 637 O
diagnosis 119 128 638 647 O
( 129 130 648 649 O
stage 130 135 649 654 O
4 136 137 655 656 O
) 137 138 656 657 O

History 0 7 658 665 O
of 8 10 666 668 O
allergy 11 18 669 676 O
to 19 21 677 679 O
Optison(TM 22 32 680 690 B-allergy_name
) 32 33 690 691 I-allergy_name
contrast 34 42 692 700 I-allergy_name
agent 43 48 701 706 I-allergy_name
or 49 51 707 709 O
blood 52 57 710 715 B-allergy_name
products 58 66 716 724 I-allergy_name

Initiation 0 10 725 735 O
of 11 13 736 738 O
chemotherapy 14 26 739 751 B-treatment
is 27 29 752 754 O
planned 30 37 755 762 O
within 38 44 763 769 O
6 45 46 770 771 B-upper_bound
weeks 47 52 772 777 I-upper_bound
( 53 54 778 779 I-upper_bound
42 54 56 779 781 I-upper_bound
days 57 61 782 786 I-upper_bound
) 61 62 786 787 I-upper_bound
of 63 65 788 790 O
the 66 69 791 794 O
definitive 70 80 795 805 O
biopsy 81 87 806 812 B-treatment
or 88 90 813 815 O
surgical 91 99 816 824 B-treatment
resection 100 109 825 834 I-treatment

Low 0 3 835 838 O
- 3 4 838 839 O
risk 4 8 839 843 O
: 8 9 843 844 O
Embryonal 10 19 845 854 B-cancer
, 19 20 854 855 O
botryoid 21 29 856 864 B-cancer
, 29 30 864 865 O
spindle 31 38 866 873 B-cancer
cell 39 43 874 878 I-cancer
tumors 44 50 879 885 I-cancer
only 51 55 886 890 O
( 56 57 891 892 O
Subset 57 63 892 898 O
1 64 65 899 900 O
: 65 66 900 901 O
Stage 67 72 902 907 O
1 73 74 908 909 O
, 74 75 909 910 O
Group 76 81 911 916 O
I 82 83 917 918 O
; 83 84 918 919 O
Stage 85 90 920 925 O
1 91 92 926 927 O
Group 93 98 928 933 O
I 99 100 934 935 O
; 100 101 935 936 O
Stage 102 107 937 942 O
1 108 109 943 944 O
Group 110 115 945 950 O
III 116 119 951 954 O
orbital 120 127 955 962 O
only 128 132 963 967 O
; 132 133 967 968 O
Stage 134 139 969 974 O
2 140 141 975 976 O
Group 142 147 977 982 O
I 148 149 983 984 O
; 149 150 984 985 O
Stage 151 156 986 991 O
2 157 158 992 993 O
Group 159 164 994 999 O
II 165 167 1000 1002 O
) 167 168 1002 1003 O
( 169 170 1004 1005 O
Subset 170 176 1005 1011 O
2 177 178 1012 1013 O
: 178 179 1013 1014 O
Stage 180 185 1015 1020 O
1 186 187 1021 1022 O
Group 188 193 1023 1028 O
III 194 197 1029 1032 O
non 198 201 1033 1036 O
orbit 202 207 1037 1042 O
; 207 208 1042 1043 O
Stage 209 214 1044 1049 O
3 215 216 1050 1051 O
Group 217 222 1052 1057 O
I 223 224 1058 1059 O
, 224 225 1059 1060 O
II 226 228 1061 1063 O
) 228 229 1063 1064 O

Newly 0 5 1065 1070 O
diagnosed 6 15 1071 1080 O
participants 16 28 1081 1093 O
with 29 33 1094 1098 O
localized 34 43 1099 1108 O
rhabdomyosarcoma 44 60 1109 1125 B-cancer
( 61 62 1126 1127 I-cancer
RMS 62 65 1127 1130 I-cancer
) 65 66 1130 1131 I-cancer

Newly 0 5 1132 1137 O
diagnosis 6 15 1138 1147 O
or 16 18 1148 1150 O
suspected 19 28 1151 1160 O
diagnosis 29 38 1161 1170 O
of 39 41 1171 1173 O
previously 42 52 1174 1184 O
untreated 53 62 1185 1194 O
participants 63 75 1195 1207 O
with 76 80 1208 1212 O
rhabdomyosarcoma 81 97 1213 1229 B-cancer
( 98 99 1230 1231 I-cancer
RMS 99 102 1231 1234 I-cancer
) 102 103 1234 1235 I-cancer

No 0 2 1236 1238 O
evidence 3 11 1239 1247 O
of 12 14 1248 1250 O
active 15 21 1251 1257 B-chronic_disease
, 21 22 1257 1258 O
uncontrolled 23 35 1259 1271 B-chronic_disease
infection 36 45 1272 1281 I-chronic_disease

Participant 0 11 1282 1293 O
has 12 15 1294 1297 O
received 16 24 1298 1306 O
no 25 27 1307 1309 O
prior 28 33 1310 1315 B-treatment
radiotherapy 34 46 1316 1328 I-treatment
or 47 49 1329 1331 O
chemotherapy 50 62 1332 1344 B-treatment
for 63 66 1345 1348 I-treatment
rhabdomyosarcoma 67 83 1349 1365 I-treatment
( 84 85 1366 1367 O
excluding 85 94 1367 1376 O
steroids 95 103 1377 1385 B-treatment
) 103 104 1385 1386 O
unless 105 111 1387 1393 O
an 112 114 1394 1396 O
emergency 115 124 1397 1406 O
situation 125 134 1407 1416 O
requires 135 143 1417 1425 O
local 144 149 1426 1431 O
tumor 150 155 1432 1437 B-cancer
treatment 156 165 1438 1447 B-treatment

Participants 0 12 1448 1460 O
treated 13 20 1461 1468 O
on 21 23 1469 1471 O
this 24 28 1472 1476 O
protocol 29 37 1477 1485 O
in 38 40 1486 1488 O
the 41 44 1489 1492 O
low 45 48 1493 1496 O
or 49 51 1497 1499 O
intermediate 52 64 1500 1512 O
risk 65 69 1513 1517 O
arm 70 73 1518 1521 O
who 74 77 1522 1525 O
experience 78 88 1526 1536 O
disease 89 96 1537 1544 O
progression 97 108 1545 1556 O
prior 109 114 1557 1562 B-upper_bound
to 115 117 1563 1565 I-upper_bound
week 118 122 1566 1570 I-upper_bound
13 123 125 1571 1573 I-upper_bound
will 126 130 1574 1578 O
transfer 131 139 1579 1587 O
to 140 142 1588 1590 O
the 143 146 1591 1594 O
high 147 151 1595 1599 O
risk 152 156 1600 1604 O
arm 157 160 1605 1608 O
and 161 164 1609 1612 O
proceed 165 172 1613 1620 O
with 173 177 1621 1625 O
high 178 182 1626 1630 O
risk 183 187 1631 1635 O
chemotherapy 188 200 1636 1648 B-treatment
starting 201 209 1649 1657 O
at 210 212 1658 1660 O
week 213 217 1661 1665 O
1 218 219 1666 1667 O
of 220 222 1668 1670 O
the 223 226 1671 1674 O
protocol 227 235 1675 1683 O

Participants 0 12 1684 1696 O
with 13 17 1697 1701 O
biliary 18 25 1702 1709 O
or 26 28 1710 1712 O
hepatic 29 36 1713 1720 O
primaries 37 46 1721 1730 O
with 47 51 1731 1735 O
bilirubin 52 61 1736 1745 B-clinical_variable
values 62 68 1746 1752 O
greater 69 76 1753 1760 O
than 77 81 1761 1765 O
1.5 82 85 1766 1769 B-upper_bound
x 86 87 1770 1771 I-upper_bound
ULN 88 91 1772 1775 I-upper_bound
may 92 95 1776 1779 O
be 96 98 1780 1782 O
enrolled 99 107 1783 1791 O
on 108 110 1792 1794 O
study 111 116 1795 1800 O
if 117 119 1801 1803 O
all 120 123 1804 1807 O
other 124 129 1808 1813 O
eligibility 130 141 1814 1825 O
criteria 142 150 1826 1834 O
are 151 154 1835 1838 O
met 155 158 1839 1842 O

Participants 0 12 1843 1855 O
with 13 17 1856 1860 O
urinary 18 25 1861 1868 O
tract 26 31 1869 1874 O
obstruction 32 43 1875 1886 O
by 44 46 1887 1889 O
tumor 47 52 1890 1895 B-cancer
must 53 57 1896 1900 O
meet 58 62 1901 1905 O
the 63 66 1906 1909 O
renal 67 72 1910 1915 O
function 73 81 1916 1924 O
criteria 82 90 1925 1933 O
listed 91 97 1934 1940 O
above 98 103 1941 1946 O
AND 104 107 1947 1950 O
must 108 112 1951 1955 O
have 113 117 1956 1960 O
unimpeded 118 127 1961 1970 O
urinary 128 135 1971 1978 O
flow 136 140 1979 1983 O
established 141 152 1984 1995 O
via 153 156 1996 1999 O
decompression 157 170 2000 2013 O
of 171 173 2014 2016 O
the 174 177 2017 2020 O
obstructed 178 188 2021 2031 O
portion 189 196 2032 2039 O
of 197 199 2040 2042 O
the 200 203 2043 2046 O
urinary 204 211 2047 2054 O
tract 212 217 2055 2060 O

Patients 0 8 2061 2069 O
requiring 9 18 2070 2079 O
emergency 19 28 2080 2089 O
radiation 29 38 2090 2099 B-treatment
therapy 39 46 2100 2107 I-treatment
are 47 50 2108 2111 O
eligible 51 59 2112 2120 O
for 60 63 2121 2124 O
enrollment 64 74 2125 2135 O
on 75 77 2136 2138 O
this 78 82 2139 2143 O
study 83 88 2144 2149 O

Performance 0 11 2150 2161 O
level 12 17 2162 2167 O
corresponding 18 31 2168 2181 O
to 32 34 2182 2184 O
ECOG 35 39 2185 2189 B-clinical_variable
score 40 45 2190 2195 I-clinical_variable
of 46 48 2196 2198 O
0 49 50 2199 2200 B-lower_bound
, 50 51 2200 2201 O
1 52 53 2202 2203 O
, 53 54 2203 2204 O
or 55 57 2205 2207 O
2 58 59 2208 2209 B-lower_bound

Peripheral 0 10 2210 2220 B-clinical_variable
absolute 11 19 2221 2229 I-clinical_variable
neutrophil 20 30 2230 2240 I-clinical_variable
count 31 36 2241 2246 I-clinical_variable
( 37 38 2247 2248 I-clinical_variable
ANC 38 41 2248 2251 I-clinical_variable
) 41 42 2251 2252 I-clinical_variable
≥ 43 44 2253 2254 O
750 45 48 2255 2258 B-lower_bound
/ 48 49 2258 2259 I-lower_bound
μL 49 51 2259 2261 I-lower_bound

Platelet 0 8 2262 2270 B-clinical_variable
count 9 14 2271 2276 I-clinical_variable
≥ 15 16 2277 2278 O
75,000 17 23 2279 2285 B-lower_bound
/ 23 24 2285 2286 I-lower_bound
μL 24 26 2286 2288 I-lower_bound
( 27 28 2289 2290 O
transfusion 28 39 2290 2301 O
independent 40 51 2302 2313 O
) 51 52 2313 2314 O

Prior 0 5 2315 2320 B-treatment
biopsy 6 12 2321 2327 I-treatment
, 12 13 2327 2328 O
surgical 14 22 2329 2337 B-treatment
resection 23 32 2338 2347 I-treatment
and 33 36 2348 2351 O
lymph 37 42 2352 2357 O
node 43 47 2358 2362 O
sampling 48 56 2363 2371 O
is 57 59 2372 2374 O
allowed 60 67 2375 2382 O

Serum 0 5 2383 2388 B-chronic_disease
creatinine 6 16 2389 2399 I-chronic_disease
based 17 22 2400 2405 O
on 23 25 2406 2408 O
age 26 29 2409 2412 B-age
and 30 33 2413 2416 O
gender 34 40 2417 2423 O

Sexually 0 8 2424 2432 O
active 9 15 2433 2439 O
patients 16 24 2440 2448 O
of 25 27 2449 2451 O
childbearing 28 40 2452 2464 O
potential 41 50 2465 2474 O
must 51 55 2475 2479 O
be 56 58 2480 2482 O
willing 59 66 2483 2490 B-contraception_consent
to 67 69 2491 2493 I-contraception_consent
use 70 73 2494 2497 I-contraception_consent
effective 74 83 2498 2507 I-contraception_consent
contraception 84 97 2508 2521 I-contraception_consent
during 98 104 2522 2528 O
therapy 105 112 2529 2536 B-treatment
and 113 116 2537 2540 O
for 117 120 2541 2544 O
at 121 123 2545 2547 O
least 124 129 2548 2553 O
1 130 131 2554 2555 B-lower_bound
month 132 137 2556 2561 I-lower_bound
after 138 143 2562 2567 I-lower_bound
treatment 144 153 2568 2577 B-treatment
is 154 156 2578 2580 O
completed 157 166 2581 2590 O

The 0 3 2591 2594 O
Lansky 4 10 2595 2601 B-clinical_variable
performance 11 22 2602 2613 I-clinical_variable
score 23 28 2614 2619 I-clinical_variable
should 29 35 2620 2626 O
be 36 38 2627 2629 O
used 39 43 2630 2634 O
for 44 47 2635 2638 O
participants 48 60 2639 2651 O
< 61 62 2652 2653 O
16 63 65 2654 2656 B-upper_bound
years 66 71 2657 2662 I-upper_bound

Undergoing 0 10 2663 2673 O
upfront 11 18 2674 2681 O
surgical 19 27 2682 2690 B-treatment
resection 28 37 2691 2700 I-treatment
of 38 40 2701 2703 O
the 41 44 2704 2707 O
primary 45 52 2708 2715 O
tumor 53 58 2716 2721 B-cancer

